Cargando…
Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
Polycystic ovary syndrome (PCOS) is extremely heterogeneous in terms of clinical manifestations. The variability of the syndrome’s phenotype is derived from the genetic and molecular heterogeneity, with a great deal of environmental factors that may have long-term health consequences, such as metabo...
Autores principales: | Pandurevic, Srdan, Macut, Djuro, Fanelli, Flaminia, Pagotto, Uberto, Gambineri, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467803/ https://www.ncbi.nlm.nih.gov/pubmed/34572562 http://dx.doi.org/10.3390/biom11091350 |
Ejemplares similares
-
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
por: Livadas, Sarantis, et al.
Publicado: (2023) -
Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial
por: Pandurevic, Srdjan, et al.
Publicado: (2023) -
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes: Results From a Long-Term Prospective Study
por: Gambineri, Alessandra, et al.
Publicado: (2012) -
Predictors of Subclinical Cardiovascular Disease in Women with Polycystic Ovary Syndrome: Interrelationship of Dyslipidemia and Arterial Blood Pressure
por: Macut, Djuro, et al.
Publicado: (2015) -
MON-214 The Natural Course of Normal Weight Women with Polycystic Ovary Syndrome: An Insight into Metabolic Changes of Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2019)